GALT Polyclonal Antibody

Background:
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene.

Research Area: Cancer, Metabolism, Signal Transduction

Synonyms:
Gal 1 P uridylyltransferase, Gal-1-P uridylyltransferase, Galactose 1 phosphate uridyl transferase, Galactose 1 phosphate uridylyltransferase, Galactose-1-phosphate uridylyltransferase, GALT, GALT, UDP glucose hexose 1 phosphate uridylyltransferase, UDP-glucose--hexose-1-phosphate uridylyltransferase

Immunogen: Recombinant protein of human GALT

Swissprot: P07902
Gene Accession: NP_000146

Calculated MW: 43 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.3 mg/mL
Dilution: WB 1:500-1:2000, IHC 1:50-1:200

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-162839